Athos Therapeutics, Inc. — Form D/A

Athos Therapeutics, Inc. of TORRANCE, CA, a company, filed a Form D amendment with the SEC on 2021-11-17. The offering totals $20.4M, of which $20.4M was reported sold. Industry: Pharmaceuticals.

Offering

• Filed: 2021-11-17
• Form: D/A
• Accession: 0001885079-21-000003
• Industry: Pharmaceuticals
• Exemptions: 06b
• Total offering: $20.4M
• Amount sold: $20.4M
• Investors: 103
• Date of first sale: 2021-09-15
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-414754

Issuer

• Name: Athos Therapeutics, Inc.
• CIK: 0001885079
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2019
• Address: 1123 W. CARSON ST., TORRANCE, CA, 90502
• Phone: 857-222-0410

Officers, directors & promoters (13)

Other filings by this issuer (3)

More

• CIK 1885079 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search